We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+11.76%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.08B
AUM Growth
+$20.7M
Cap. Flow
-$60.6M
Cap. Flow %
-5.62%
Top 10 Hldgs %
20.95%
Holding
208
New
36
Increased
50
Reduced
44
Closed
33

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$22.8M
2
LEGN icon
Legend Biotech
LEGN
+$18.8M
3
DAWN
Day One Biopharmaceuticals
DAWN
+$16.1M
4
SWTX
SpringWorks Therapeutics
SWTX
+$16M
5
UTHR icon
United Therapeutics
UTHR
+$15.2M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$20M
2
HQY icon
HealthEquity
HQY
+$18.6M
3
ESI icon
Element Solutions
ESI
+$17.4M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$14.2M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 44.2%
2 Technology 15.96%
3 Industrials 9.72%
4 Energy 6.59%
5 Consumer Staples 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTDR icon
76
Matador Resources
MTDR
$6.09B
$4.71M 0.44%
96,327
+2,872
+3% +$155K
BAH icon
77
Booz Allen Hamilton
BAH
$9.15B
$4.52M 0.42%
48,940
+36,700
+300% +$3.48M
TIL icon
78
Instil Bio
TIL
$50.3M
$4.34M 0.4%
44,869
+22,691
+102% +$2.6M
NVDA icon
79
NVIDIA
NVDA
$5.42T
$4.32M 0.4%
356,100
-109,350
-23% -$1.73M
TEAM icon
80
Atlassian
TEAM
$37.8B
$4.25M 0.39%
20,176
+5,625
+39% +$1.31M
KLAC icon
81
KLA
KLAC
$259B
$3.98M 0.37%
131,550
-18,330
-12% -$635K
JBHT icon
82
JB Hunt Transport Services
JBHT
$25.2B
$3.85M 0.36%
24,612
– –
ISEE
83
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$3.77M 0.35%
209,976
-1,080,077
-84% -$14.2M
ASML icon
84
ASML
ASML
$669B
$3.76M 0.35%
9,057
– –
CLH icon
85
Clean Harbors
CLH
$16.3B
$3.71M 0.34%
+33,691
New +$3.61M
GO icon
86
Grocery Outlet
GO
$980M
$3.54M 0.33%
106,201
-88,492
-45% -$3.6M
TAP icon
87
Molson Coors Class B
TAP
$8.09B
$3.5M 0.32%
73,000
-1,290
-2% -$70K
FRPT icon
88
Freshpet
FRPT
$3.22B
$3.46M 0.32%
+68,991
New +$3.25M
ZNTL icon
89
Zentalis Pharmaceuticals
ZNTL
$302M
$3.44M 0.32%
+158,704
New +$4.34M
EVA
90
DELISTED
Enviva Inc.
EVA
$3.43M 0.32%
57,078
-38,716
-40% -$2.6M
LXU icon
91
LSB Industries
LXU
$693M
$3.4M 0.32%
238,527
+53,222
+29% +$753K
CTRA
92
DELISTED
Coterra Energy
CTRA
$3.4M 0.31%
130,000
-36,169
-22% -$1.04M
INTU icon
93
Intuit
INTU
$89B
$3.15M 0.29%
8,126
+1,962
+32% +$848K
ABBV icon
94
AbbVie
ABBV
$435B
$3.06M 0.28%
22,800
-10,380
-31% -$1.49M
CLR
95
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$2.99M 0.28%
44,687
– –
LRN icon
96
Stride
LRN
$3.43B
$2.87M 0.27%
+68,340
New +$2.75M
AMD icon
97
Advanced Micro Devices
AMD
$789B
$2.85M 0.26%
44,943
– –
CCJ icon
98
Cameco
CCJ
$42.4B
$2.81M 0.26%
105,986
-49,494
-32% -$1.27M
CP icon
99
Canadian Pacific Kansas City
CP
$80.5B
$2.75M 0.25%
41,154
-2,015
-5% -$152K
ERII icon
100
Energy Recovery
ERII
$443M
$2.57M 0.24%
118,070
+10,249
+10% +$231K
2 3
4
5 6

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Nicholas Investment Partners held 208 positions worth $1.08B, up 2% from $1.06B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners withdrew a net $60.6M in Q3 2022, closing 33 positions and reducing 44 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Cytokinetics worth $22.9M.

  • Nicholas Investment Partners's largest Q3 2022 buy was Cytokinetics: 472,839 shares worth $22.9M.
  • Nicholas Investment Partners added most to Callaway Golf Company in Q3 2022, an estimated $9.5M increase.
  • Nicholas Investment Partners's biggest Q3 2022 reduction was IVERIC bio, Inc. Common Stock, cutting an estimated $14.2M.
  • Nicholas Investment Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $20M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $1.08B portfolio in Q3 2022.
  • Nicholas Investment Partners opened 36 new positions and closed 33 in Q3 2022.
  • Nicholas Investment Partners's portfolio value rose 2% quarter-over-quarter to $1.08B.

Based on Nicholas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.